Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Mol Carcinog. 2017 Sep 2;56(11):2382–2390. doi: 10.1002/mc.22635

Figure 4.

Figure 4

Time course of candidate miRNA expression in liver tissue during the 4 week dosing period measured by RT-qPCR in a-b) aflatoxin only treated samples; majority of miRNAs (except 34a, 122, 429, and 221) have a significant increase in expression from week 1 to week 3; majority of miRNAs (except 34a and 122) are significantly increased in expression from week 1 to week 4 of aflatoxin treatment; and c–d) aflatoxin plus CDDO-Im treated samples; no significant change in expression from week 1 to week 4 for all miRNAs except miR-181c; significant decrease in expression of miRs 429 and 221 from week 1 to week 3.